GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: VNRX-5133 | VNRX5133
Compound class:
Synthetic organic
Comment: Taniborbactam (VNRX-5133) is a clinical stage, injectable, broad-spectrum β-lactamase inhibitor [1,3]. It has activity against both serine- and metallo-β-lactamases (e.g. oxacillinase, Klebsiella pneumoniae carbapenemase, New Delhi metallo-beta-lactamase, Verona integron-encoded metallo-beta-lactamase and extended spectrum beta-lactamase) [4]. Taniborbactam will be administered alongside the cephalosporin antibacterial cefepime. It is being developed by Venatorx Pharmaceuticals in partnership with the Global Antibiotic Research & Development Partnership (GARDP).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (3R)-3-[[2-[4-(2-aminoethylamino)cyclohexyl]acetyl]amino]-2-hydroxy-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10817 | taniborbactam |
Synonyms ![]() |
| VNRX-5133 | VNRX5133 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Cefepime + Taniborbactam |
| Other databases | |
| CAS Registry No. | 1613267-49-4 (source: WHO INN record) |
| GtoPdb PubChem SID | 405560215 |
| PubChem CID | 76902493 |
| RCSB PDB Ligand | KJK |
| Search Google for chemical match using the InChIKey | PFZUWUXKQPRWAL-PXCJXSSVSA-N |
| Search Google for chemicals with the same backbone | PFZUWUXKQPRWAL |
| Search PubMed clinical trials | taniborbactam |
| Search PubMed titles | taniborbactam |
| Search PubMed titles/abstracts | taniborbactam |
| UniChem Compound Search for chemical match using the InChIKey | PFZUWUXKQPRWAL-PXCJXSSVSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | PFZUWUXKQPRWAL-PXCJXSSVSA-N |